
Analysts Viewpoint
Taking a Closer Look At Arrowhead Pharmaceuticals Inc (ARWR) Following Its Recent Trade
Arrowhead Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Anzalone Christopher Richard unloaded Company’s shares for reported $0.58